WallStreetZenWallStreetZen

NYSEMKT: KAPA
Kairos Pharma Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for KAPA

Based on 3 analysts offering 12 month price targets for Kairos Pharma Ltd

Min Forecast
$4.00+503.32%
Avg Forecast
$8.33+1,156.86%
Max Forecast
$12.00+1,709.95%

Should I buy or sell KAPA stock?

Based on 3 analysts offering ratings for Kairos Pharma Ltd.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although KAPA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates KAPA as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their KAPA stock forecasts and price targets.

KAPA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-04
lockedlocked$00.00+00.00%2025-04-03
lockedlocked$00.00+00.00%2025-03-27

1 of 1

KAPA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KAPA$0.65$8.33+1,180.03%Strong Buy
BCDA$2.12N/AN/A
XFOR$1.89$48.50+2,466.14%Strong Buy
TAOX$7.85N/AN/A
CYCN$3.36N/AN/A
View Top Biotech Stocks

Kairos Pharma Stock Forecast FAQ

Is Kairos Pharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSEMKT: KAPA) stock is to Strong Buy KAPA stock.

Out of 3 analysts, 2 (66.67%) are recommending KAPA as a Strong Buy, 1 (33.33%) are recommending KAPA as a Buy, 0 (0%) are recommending KAPA as a Hold, 0 (0%) are recommending KAPA as a Sell, and 0 (0%) are recommending KAPA as a Strong Sell.

If you're new to stock investing, here's how to buy Kairos Pharma stock.

What is KAPA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year KAPA price target, the average KAPA price target is $8.33, with the highest KAPA stock price forecast at $12.00 and the lowest KAPA stock price forecast at $4.00.

On average, Wall Street analysts predict that Kairos Pharma's share price could reach $8.33 by Jun 4, 2026. The average Kairos Pharma stock price prediction forecasts a potential upside of 1,180.03% from the current KAPA share price of $0.65.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.